Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-22

FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved an original application for Desmopressin Acetate from Sagent Pharmaceuticals, establishing a generic version of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin Acetate (Desmopressin acetate)

Snippet

ORIG AP for DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE)